Opportunity Information: Apply for RFA HS 22 001
The Agency for Healthcare Research and Quality (AHRQ) grant opportunity titled "Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)" (Funding Opportunity Number RFA-HS-22-001; CFDA 93.226) supports projects that take existing patient-centered outcomes research evidence and actively put it into practice in real-world healthcare settings. The core idea is not to generate new clinical evidence from scratch, but to spread and implement proven, evidence-based approaches in ways that measurably reduce disparities in health outcomes and care quality experienced by racial and ethnic minority groups and other AHRQ priority populations. AHRQ is looking for work that is practical, scalable, and grounded in PCOR findings, with a strong emphasis on dissemination and implementation strategies that can change systems of care.
Projects funded under this NOFO are expected to deploy innovative, evidence-based interventions across healthcare environments in order to close gaps in outcomes and quality. The interventions must be designed around improving the uptake, consistency, and effectiveness of evidence-based strategies, and they should clearly connect implementation activities to the specific goal of reducing health and healthcare disparities. While applicants have flexibility in choosing the condition area and setting, the announcement highlights several domains where evidence-based interventions have already shown promise in reducing disparities. These include improving control and long-term management of chronic conditions such as cardiovascular disease, increasing appropriate cancer and chronic condition screening, and improving prenatal care, maternal health outcomes, and infant mortality. In practice, this points to projects that help health systems, clinics, community partners, and other service settings consistently deliver evidence-backed care to populations that have historically faced barriers to access, continuity, trust, and high-quality treatment.
The opportunity uses the R18 research demonstration and dissemination grant mechanism and is categorized as discretionary grant funding within the health activity area. The posted award ceiling is $1,500,000 per award. The NOFO was created on May 26, 2022, with an original closing date of June 17, 2022. Although the excerpt does not specify the expected number of awards, the intent is to fund a set of implementation-focused projects that can serve as models for broader adoption, especially when they demonstrate effective strategies for overcoming structural, organizational, cultural, geographic, and workflow barriers that contribute to disparities.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofit organizations (both 501(c)(3) and non-501(c)(3), excluding institutions of higher education in those categories); for-profit organizations other than small businesses; and small businesses. The NOFO also calls out additional eligible applicant types and community-anchored institutions that commonly serve priority populations, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, eligible federal agencies, and Indian/Native American tribal governments other than federally recognized entities.
At the same time, the announcement is explicit about limits related to foreign participation. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible to apply, meaning the applicant and the proposed operational components supported by the award must be U.S.-based.
Overall, this funding opportunity is aimed at moving PCOR evidence off the page and into everyday care in ways that directly address inequities. Competitive applications would be expected to clearly identify a disparity in a chronic condition area, select PCOR-supported interventions that can realistically be adopted in the chosen settings, and build a strong dissemination and implementation approach that improves reach, adoption, fidelity, and sustainability among the populations experiencing the greatest burdens. The end goal is straightforward: better, more equitable outcomes and quality of care for racial and ethnic minority populations and other AHRQ priority groups through real-world implementation of what is already known to work.Apply for RFA HS 22 001
- The Agency for Health Care Research and Quality in the health sector is offering a public funding opportunity titled "Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226.
- This funding opportunity was created on 2022-05-26.
- Applicants must submit their applications by 2022-06-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: Agency for Health Care Research and Quality
Browse more opportunities from the same category: Health
Next opportunity: U.S. Embassy Sofia PDS Annual Program Statement
Previous opportunity: NEA American Rescue Plan Grants to Organizations #2, FY2021
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HS 22 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HS 22 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Resource Center for Tribal Epidemiological Centers (RC-TEC) (U24 Clinical Trial Not Allowed) Apply for RFA MD 21 003 Funding Number: RFA MD 21 003 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed) Apply for PAR 22 024 Funding Number: PAR 22 024 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Creating an Educational Nexus for Training in Experimental Rigor (CENTER) (UC2 Clinical Trial Not Allowed) Apply for RFA NS 21 009 Funding Number: RFA NS 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) Apply for PAR 21 307 Funding Number: PAR 21 307 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) Apply for PAR 21 308 Funding Number: PAR 21 308 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA DE 22 005 Funding Number: RFA DE 22 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) Apply for PAR 21 316 Funding Number: PAR 21 316 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 013 Funding Number: RFA RM 21 013 Agency: National Institutes of Health Category: Health Funding Amount: $7,200,000 |
| Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed) Apply for PAR 22 026 Funding Number: PAR 22 026 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21 Clinical Trial Not Allowed) Apply for RFA MH 21 251 Funding Number: RFA MH 21 251 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional) Apply for RFA MH 21 250 Funding Number: RFA MH 21 250 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention and Alcohol (R01 Clinical Trials Optional) Apply for RFA AA 21 016 Funding Number: RFA AA 21 016 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| HIV Prevention and Alcohol (R34 Clinical Trials Optional) Apply for RFA AA 21 017 Funding Number: RFA AA 21 017 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) Apply for PAR 21 282 Funding Number: PAR 21 282 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed) Apply for RFA RM 21 014 Funding Number: RFA RM 21 014 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
| Tanzania Malaria Case Management Activity (TMCM) Apply for RFI 621 21 HO 001 Funding Number: RFI 621 21 HO 001 Agency: Tanzania USAID-Dar es Salaam Category: Health Funding Amount: Case Dependent |
| HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional) Apply for RFA NS 22 016 Funding Number: RFA NS 22 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 21 317 Funding Number: PAR 21 317 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed) Apply for PAR 22 029 Funding Number: PAR 22 029 Agency: National Institutes of Health Category: Health Funding Amount: $630,000 |
| NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) Apply for PAR 22 022 Funding Number: PAR 22 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HS 22 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.